These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8095536)

  • 1. Dependency of salivary excretion of mexiletine on the plasma concentration in rats.
    Nagasako S; Iwamoto K; Hayashibara M; Katagiri Y
    J Pharm Pharmacol; 1993 Feb; 45(2):154-6. PubMed ID: 8095536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary excretion of mexiletine after bolus intravenous administration in rats.
    Nagasako S; Hayashibara M; Katagiri Y; Iwamoto K
    J Pharm Pharmacol; 1992 Jan; 44(1):55-7. PubMed ID: 1350630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary excretion of 5-fluorouracil (5-FU). IV. Dependency of saliva/plasma concentration ratio and salivary clearance on plasma concentration of 5-FU during constant-rate intravenous infusion in rats.
    Hayashi Y; Watanabe J; Ozeki S
    J Pharmacobiodyn; 1989 Mar; 12(3):137-44. PubMed ID: 2760793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary excretion of 5-fluorouracil. II. Fluctuation of saliva/plasma concentration ratio and salivary clearance during a constant rate intravenous infusion in beagle dogs.
    Hayashi Y; Watanabe J; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1988 Jun; 11(6):438-43. PubMed ID: 3171885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mandibular and parotid salivary excretion of procainamide and N-acetylprocainamide after intravenous administration of procainamide to rats.
    Watanabe J; Koyama I; Iwamoto K; Ozeki S
    J Pharm Pharmacol; 1987 Nov; 39(11):912-6. PubMed ID: 2448449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of mexiletine enantiomers in healthy human subjects. A study of the in vivo serum protein binding, salivary excretion and red blood cell distribution of the enantiomers.
    Kwok DW; Kerr CR; McErlane KM
    Xenobiotica; 1995 Nov; 25(10):1127-42. PubMed ID: 8578769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary excretion of mexiletine in normal healthy volunteers.
    Katagiri Y; Nagasako S; Hayashibara M; Iwamoto K
    J Pharm Pharmacol; 1991 Jul; 43(7):513-5. PubMed ID: 1682467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correspondence of salivary and plasma concentrations of atrazine in rats under variable salivary flow rate and plasma concentration.
    Lu C; Anderson LC; Morgan MS; Fenske RA
    J Toxicol Environ Health; 1997 Nov; 52(4):317-29. PubMed ID: 9354177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excretion of ofloxacin into saliva in rats with renal failure.
    Ding G; Naora K; Nagasako S; Hirano H; Iwamoto K
    J Pharmacol Exp Ther; 1998 Oct; 287(1):31-6. PubMed ID: 9765318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study on salivary distribution of fluoroquinolones in rats.
    Li Q; Naora K; Hirano H; Okunishi H; Iwamoto K
    Biol Pharm Bull; 2002 Aug; 25(8):1084-9. PubMed ID: 12186414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein binding effects of salivary excretion of phenobarbital in dogs.
    Watanabe J; Nakase Y; Urasaki Y; Hayashi Y; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1981 Dec; 4(12):968-77. PubMed ID: 7341753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations of parotid saliva and plasma lidocaine concentrations in rats.
    DiGregorio GJ; Piraino AJ; Ruch E
    J Pharm Sci; 1979 Sep; 68(9):1192-3. PubMed ID: 501552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary excretion of urea in dogs.
    Watanabe J; Mizuno S; Masuda N; Hayashi Y; Iwamoto K; Hirate J; Ozeki S
    J Pharmacobiodyn; 1984 May; 7(5):294-303. PubMed ID: 6470927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretion of indomethacin into saliva following intravenous administration to dogs.
    Watanabe J; Urasaki Y; Nakase Y; Ueda H; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1981 May; 4(5):336-44. PubMed ID: 7288551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological monitoring of diazinon exposure using saliva in an animal model.
    Lu C; Irish RM; Fenske R
    J Toxicol Environ Health A; 2003 Dec; 66(24):2315-25. PubMed ID: 14630523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of flow rate, pH and plasma fluoride concentrations on fluoride concentration in human parotid saliva.
    Oliveby A; Lagerlöf F; Ekstrand J; Dawes C
    Arch Oral Biol; 1989; 34(3):191-4. PubMed ID: 2818268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary flow induction by buccal permucosal pilocarpine in anesthetized beagle dogs.
    Weaver ML; Tanzer JM; Kramer PA
    J Dent Res; 1992 Nov; 71(11):1762-7. PubMed ID: 1401437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mandibular and parotid salivary levels of indomethacin following intravenous administration to rabbits.
    Watanabe J; Setoyama T; Iwamoto K; Hayashi Y; Ozeki S
    Pharm Res; 1985 Jul; 2(4):185-7. PubMed ID: 24272812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of perfused rat mandibular-gland pHI on the ratio of procainamide concentration in saliva to that in venous effluent.
    Iwamoto K; Watanabe J; Kanai Y; Mizuno S; Ozeki S
    Biochem Pharmacol; 1988 Apr; 37(8):1519-23. PubMed ID: 3358782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilocarpine disposition and salivary flow responses following intravenous administration to dogs.
    Weaver ML; Tanzer JM; Kramer PA
    Pharm Res; 1992 Aug; 9(8):1064-9. PubMed ID: 1409379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.